A clinical study based on a Mexican population also indicated that Annexin II is meaningful for both APS clinical diagnosis and mechanistic research, as the positive rate of anti-Annexin II antibodies in the serum of APS and SLE patients was significantly higher than that in healthy individuals and patients without thrombosis (60). This evidence concerns the gene ANXA2 and autoimmune polyendocrinopathy.